Choosing which EGFR inhibitor to use in second line treatment of mCRC patients At Annual Meeting GI 2016

Alan P. Venook, MD of University of California San Francisco discusses which EGFR inhibitor to use in second line treatment of mCRC patients at ASCO GI 2016